Piper Sandler’s Christopher Raymond joins ‘Fast Money’ to talk Amgen’s stock sinking on GLP-1 results.
Source link
Trending
- Kremlin warns against speculation that Russia shot down Azerbaijan Airlines flight
- What has gotten into Kirby Smart? ‘I just want to fight for my team and fight for our program’
- How to invest $50,000 in 2025 for biggest returns with some risk
- AVGO, HMC, GME, KULR and more
- India’s former PM Manmohan Singh dies aged 92
- Those who never doubted Cameron Skattebo share validation: ‘No one understood what we were looking at’
- The worst-performing Dow stocks in 2025: Analysts’ predictions
- Mark Cuban tried to invest in Musical.ly before it became TikTok
Wait for longer-term data with Amgen's GLP-1, says Piper Sandler's Christopher Raymond
